(a)There is established an infant mortality review committee within the department to conduct a comprehensive, multidisciplinary review of infant deaths for purposes of reducing health care disparities, identifying factors associated with infant deaths and making recommendations to reduce infant deaths.
(b)The cochairpersons of the infant mortality review committee shall be the Commissioner of Public Health, or the commissioner's designee, and a representative designated by the Connecticut chapter of the American Academy of Pediatrics. The cochairpersons shall convene a meeting of the infant mortality review committee upon the request of the Commissioner of Public Health.
(c)The infant mortality review committee may include, but need not be limited to, any of the following members, as n
Free access — add to your briefcase to read the full text and ask questions with AI
(a) There is established an infant mortality review committee within the department to conduct a comprehensive, multidisciplinary review of infant deaths for purposes of reducing health care disparities, identifying factors associated with infant deaths and making recommendations to reduce infant deaths. (b) The cochairpersons of the infant mortality review committee shall be the Commissioner of Public Health, or the commissioner's designee, and a representative designated by the Connecticut chapter of the American Academy of Pediatrics. The cochairpersons shall convene a meeting of the infant mortality review committee upon the request of the Commissioner of Public Health. (c) The infant mortality review committee may include, but need not be limited to, any of the following members, as needed, depending on the infant death case being reviewed: (1) A physician licensed pursuant to chapter 370, who specializes in obstetrics and gynecology, designated by the Connecticut Chapter of the American College of Obstetrics and Gynecology; (2) A community health worker, designated by the Commission on Women, Children, Seniors, Equity and Opportunity; (3) A pediatric nurse licensed pursuant to chapter 378, designated by the Connecticut Nurses Association; (4) A clinical social worker licensed pursuant to chapter 383b, designated by the Connecticut Chapter of the National Association of Social Workers; (5) The Chief Medical Examiner, or the Chief Medical Examiner's designee; (6) A member of the Connecticut Hospital Association representing a pediatric facility; (7) A representative of The University of Connecticut-sponsored Health Disparities Institute; (8) A physician licensed pursuant to chapter 370, who practices neonatology, designated by the Connecticut Medical Society; (9) A physician assistant licensed pursuant to chapter 370 or advanced practice registered nurse licensed pursuant to chapter 378, designated by an association representing physician assistants or advanced practice registered nurses in the state; (10) The Child Advocate, or the Child Advocate's designee; (11) The Commissioner of Social Services, or the commissioner's designee; (12) The Commissioner of Children and Families, or the commissioner's designee; (13) The Commissioner of Early Childhood, or the commissioner's designee; (14) The Commissioner of Mental Health and Addiction Services, or the commissioner's designee; and (15) Any additional member the cochairpersons determine would be beneficial to serve as a member of the committee. (d) For any infant mortality review, the committee may consult with relevant experts to evaluate the information and findings obtained from the department pursuant to section 19a-59j and make recommendations regarding the prevention of infant deaths. (e) The infant mortality review committee shall include available infant death reports and recommendations produced by the child fatality review panel, established pursuant to section 46a-13 l , in its review of infant deaths for the purposes of making recommendations to reduce health care disparities and identify gaps in or problems with the delivery of care or services to reduce infant deaths. (f) Not later than ninety days after completing an infant mortality review, the committee shall, in consultation with the Office of the Child Advocate, report to the Commissioner of Public Health the recommendations and findings of the committee in a manner that complies with section 19a-25 . (g) All information provided by the department to the infant mortality review committee or provided to any expert consulted by the committee shall be subject to the provisions of section 19a-25 .